Edition:
United States

Akari Therapeutics PLC (AKTX.OQ)

AKTX.OQ on NASDAQ Stock Exchange Capital Market

4.17USD
15 Dec 2017
Change (% chg)

$0.04 (+0.97%)
Prev Close
$4.13
Open
$4.13
Day's High
$4.24
Day's Low
$3.92
Volume
82,572
Avg. Vol
96,685
52-wk High
$22.16
52-wk Low
$3.21

Get access to over 18 million research reports from over 1,700 sources.

For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.

Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.

Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:

  • ownership
  • filings
  • deals
  • private equity
  • third-party document and information retrieval
  • estimates
  • fundamentals
  • economics
  • events
  • news
  • and much, much more…

Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.

Name Age Since Current Position

Ray Prudo

2017 Chairman of the Board

David Solomon

57 2017 Chief Executive Officer

Dov Elefant

47 2012 Chief Financial Officer

Clive Richardson

2015 Chief Operating Officer, Director

Nigel Hernandez

2017 Vice President - Worldwide Regulatory Affairs